Cryosite Ltd
ASX:CTE
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.55
1.25
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CTE stock under the Base Case scenario is 0.639 AUD. Compared to the current market price of 0.895 AUD, Cryosite Ltd is Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cryosite Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CTE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cryosite Ltd
Balance Sheet Decomposition
Cryosite Ltd
Current Assets | 7.7m |
Cash & Short-Term Investments | 4.7m |
Receivables | 1.4m |
Other Current Assets | 1.6m |
Non-Current Assets | 12m |
PP&E | 1.5m |
Intangibles | 2.3m |
Other Non-Current Assets | 8.3m |
Current Liabilities | 4m |
Accounts Payable | 1.2m |
Accrued Liabilities | 284k |
Other Current Liabilities | 2.6m |
Non-Current Liabilities | 14.3m |
Long-Term Debt | 2.3m |
Other Non-Current Liabilities | 12m |
Earnings Waterfall
Cryosite Ltd
Revenue
|
12.6m
AUD
|
Cost of Revenue
|
-4.6m
AUD
|
Gross Profit
|
8m
AUD
|
Operating Expenses
|
-5.9m
AUD
|
Operating Income
|
2.1m
AUD
|
Other Expenses
|
-214k
AUD
|
Net Income
|
1.8m
AUD
|
Free Cash Flow Analysis
Cryosite Ltd
AUD | |
Free Cash Flow | AUD |
CTE Profitability Score
Profitability Due Diligence
Cryosite Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Cryosite Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
CTE Solvency Score
Solvency Due Diligence
Cryosite Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Cryosite Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CTE Price Targets Summary
Cryosite Ltd
Dividends
Current shareholder yield for CTE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CTE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.
Contact
IPO
Employees
Officers
The intrinsic value of one CTE stock under the Base Case scenario is 0.639 AUD.
Compared to the current market price of 0.895 AUD, Cryosite Ltd is Overvalued by 29%.